Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Biomolecules|May 28, 2025
Unlocking the Potential of Bioactive Compounds in Pancreatic Cancer Therapy: A Promising FrontierSilvia Brugiapaglia, Ferdinando Spagnolo, Claudia CurcioCells|September 27, 2024
Fighting Pancreatic Cancer with a Vaccine-Based Winning Combination: Hope or Reality?Silvia Brugiapaglia, Ferdinando Spagnolo, Simona Intonti, et al.Molecules (Basel, Switzerland)|April 3, 2021
The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic CancerClaudia Curcio, Silvia Brugiapaglia, Sara Bulfamante, et al.Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
The dark side of immunotherapy: pancreatic cancerGianluca Mucciolo, Cecilia Roux, Alessandro Scagliotti, et al.Frontiers in Immunology|August 23, 2024
In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigensSilvia Brugiapaglia, Sara Bulfamante, Claudia Curcio, et al.Journal of Experimental & Clinical Cancer Research : CR|June 2, 2024
PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancerClaudia Curcio, Gianluca Mucciolo, Cecilia Roux, et al.Clinical and Translational Medicine|August 20, 2025
The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenocarcinomaGiorgia Tiberi, Alessandro Scagliotti, Claudia Curcio, et al.Clinical and Experimental Medicine|November 1, 2023
Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prognostic factors for pancreatic cancer patient survivalClaudia Curcio, Tiziana Rosso, Silvia Brugiapaglia, et al.HLA|October 18, 2023
HLA-DPB1*13:01 associates with enhanced, and KIR2DS4*001 with diminished protection from developing severe COVID-19Ticiana D J Farias, Silvia Brugiapaglia, Susanna Croci, et al.Nature|November 2, 2023
IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancerNicoletta Caronni, Federica La Terza, Francesco M Vittoria, et al.Pageof 1